Cytosorbents.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  Generic medicine services are seeking approval for launch from the FDA.
  Moves Cytosorbents

  Mon 17:49
• AstraZeneca Operational
  AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.
  Moves Cytosorbents

  Mon 11:04
• Nasdaq Structural
  Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.
  Moves Cytosorbents

  Mon 17:22
• New York City Shared context
  Joint entities are driving a high volume of General Obligation bond issuance in New York City.
  Moves Cytosorbents

  Mon 15:36
• Automated Insights Mentioned together
  Zacks provided analyst estimates for Cognizant's earnings, which Automated Insights then used to generate a story.
  Moves Cytosorbents

  Sun 09:21
• Middle East Shared context
  Authorities are investigating an incident at a base in Fairford, with possible links to Iran and Russia.
  Moves Cytosorbents

  Mon 17:54

• Phillip Chan Structural

  Phillip Chan holds the formal role of Chief Executive Officer of Cytosorbents.

  Well supportedSep 4
  Cytosorbents → Phillip Chan

  Phillip Chan → Cytosorbents
• FDA Structural

  FDA regulates Cytosorbents' drug submissions, issuing denials and providing market authorization guidance.

  Some supportWed 12:13
  Cytosorbents → FDA

  FDA → Cytosorbents
• Phil Chan Structural

  Phil Chan serves as the CEO of Cytosorbents, establishing a leadership and functional dependency.

  Some supportAug 7
  Cytosorbents → Phil Chan

  Phil Chan → Cytosorbents
• Tom Shannon Structural

  Cytosorbents appointed Tom Shannon as VP of Marketing to lead marketing strategy for DrugSorb-ATR.

  SpeculativeApr 14
  Cytosorbents → Tom Shannon

  Tom Shannon → Cytosorbents
• AstraZeneca Operational

  Cytosorbents' drug product is clinically used alongside AstraZeneca's Brilinta in patients.

  SpeculativeJul 2
  Cytosorbents → AstraZeneca

  AstraZeneca → Cytosorbents
• S. Lee Operational

  S. Lee provides financial forecasts and analysis regarding Cytosorbents' earnings.

  Some supportAug 12
  Cytosorbents → S. Lee

  S. Lee → Cytosorbents
• Nasdaq Structural

  Cytosorbents must maintain minimum bid price requirements to remain listed on the Nasdaq exchange.

  Some supportWed 12:13
  Cytosorbents → Nasdaq

  Nasdaq → Cytosorbents
• New York City Shared context

  Cytosorbents holds an investor conference within New York City.

  Well supportedSep 10
  Cytosorbents → New York City

  New York City → Cytosorbents